Mie Jin Lim

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Won Park, Paweł Hrycaj, Volodymyr Kovalenko et al. · Annals of the Rheumatic Diseases · 2013 · 601 citations · Full text

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study

Won Park, Dae‐Hyun Yoo, Pedro C. Miranda et al. · Annals of the Rheumatic Diseases · 2016 · 227 citations · Full text

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis

Dae‐Hyun Yoo, Chang‐Hee Suh, Seung Cheol Shim et al. · Annals of the Rheumatic Diseases · 2016 · 81 citations · Full text

Digital Thermography of the Fingers and Toes in Raynaud's Phenomenon

Mie Jin Lim, Seong‐Ryul Kwon, Kyong‐Hee Jung et al. · Journal of Korean Medical Science · 2014 · 52 citations · Full text

Kinesiology, Thermography, Engineering +10

Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis

Won Park, Chang‐Hee Suh, Seung Cheol Shim et al. · BioDrugs · 2017 · 43 citations · Full text

Rheumatoid Disorder, Rheumatology, Medicine +8